Robert A. Wilcox

5.6k total citations
127 papers, 4.1k citations indexed

About

Robert A. Wilcox is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Robert A. Wilcox has authored 127 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 32 papers in Cardiology and Cardiovascular Medicine and 20 papers in Surgery. Recurrent topics in Robert A. Wilcox's work include Protein Kinase Regulation and GTPase Signaling (16 papers), Acute Myocardial Infarction Research (14 papers) and Animal Nutrition and Physiology (12 papers). Robert A. Wilcox is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (16 papers), Acute Myocardial Infarction Research (14 papers) and Animal Nutrition and Physiology (12 papers). Robert A. Wilcox collaborates with scholars based in United Kingdom, United States and Australia. Robert A. Wilcox's co-authors include Robert F. Storey, Stefan R. Nahorski, Stan Heptinstall, J R Hampton, Ian Macdonald, J Roland, D C Banks, R. A. John Challiss, J.R.A. Mitchell and T. Bennett and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of the American Chemical Society.

In The Last Decade

Robert A. Wilcox

125 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert A. Wilcox United Kingdom 34 2.0k 857 761 493 402 127 4.1k
Philippe Lechat France 42 3.7k 1.8× 806 0.9× 952 1.3× 377 0.8× 180 0.4× 168 7.3k
Francesca Santilli Italy 41 1.5k 0.7× 798 0.9× 682 0.9× 1.1k 2.2× 339 0.8× 131 4.6k
Lorenzo Loffredo Italy 42 1.1k 0.5× 631 0.7× 742 1.0× 467 0.9× 272 0.7× 142 5.0k
John Anthony Bauer United States 38 2.2k 1.1× 1.5k 1.8× 531 0.7× 318 0.6× 49 0.1× 139 5.3k
Shereif H. Rezkalla United States 31 2.0k 1.0× 403 0.5× 729 1.0× 209 0.4× 123 0.3× 69 3.9k
Bobby V. Khan United States 31 1.3k 0.6× 842 1.0× 905 1.2× 583 1.2× 40 0.1× 71 4.2k
Andreas J. Flammer Switzerland 36 2.3k 1.1× 849 1.0× 941 1.2× 549 1.1× 57 0.1× 136 6.1k
Susan B. Johnson United States 37 1.1k 0.6× 615 0.7× 370 0.5× 207 0.4× 81 0.2× 106 3.6k
Emanuel Raschi Italy 34 851 0.4× 636 0.7× 436 0.6× 460 0.9× 77 0.2× 169 4.1k
Marcello Ciaccio Italy 39 471 0.2× 797 0.9× 506 0.7× 449 0.9× 76 0.2× 212 4.3k

Countries citing papers authored by Robert A. Wilcox

Since Specialization
Citations

This map shows the geographic impact of Robert A. Wilcox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Wilcox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Wilcox more than expected).

Fields of papers citing papers by Robert A. Wilcox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Wilcox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Wilcox. The network helps show where Robert A. Wilcox may publish in the future.

Co-authorship network of co-authors of Robert A. Wilcox

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Wilcox. A scholar is included among the top collaborators of Robert A. Wilcox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Wilcox. Robert A. Wilcox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chau, Minh, et al.. (2023). Simple quantitative planimetric measurement of nigrosome-1 for clinical settings. Journal of the Neurological Sciences. 454. 120857–120857. 3 indexed citations
2.
Wilcox, Robert A., Adam P. Vogel, Dominic Thewlis, et al.. (2019). Use of illicit amphetamines is associated with long-lasting changes in hand circuitry and control. Clinical Neurophysiology. 130(5). 655–665. 3 indexed citations
3.
Flavel, Stanley C., Robert A. Wilcox, Dominic Thewlis, et al.. (2014). Hand Function is Altered in Individuals with a History of Illicit Stimulant Use. PLoS ONE. 9(12). e115771–e115771. 7 indexed citations
4.
Wilcox, Robert A., Susen Winkler, Katja Lohmann, & Christine Klein. (2011). Whispering dysphonia in an Australian family (DYT4): A clinical and genetic reappraisal. Movement Disorders. 26(13). 2404–2408. 43 indexed citations
5.
Gershlick, AH, Susan M. Hughes, Keith R. Abrams, et al.. (2005). for the REACT Trial Investigators. Rescue Angioplasty after Failed Thrombolytic Therapy for Acute Myocardial Infarction. New England Journal of Medicine. 2758–2768. 35 indexed citations
6.
Wilcox, Robert A., et al.. (2005). Microinjection of <I>myo</I>-Inositol(1,4,5)Trisphosphate and Other Calcium-Mobilizing Agents Into Intact Adherent Cells<U>. Humana Press eBooks. 312. 213–228. 1 indexed citations
7.
Andersen, Marcia, Robert A. Wilcox, Darlene Mood, et al.. (2005). HIV Health Care Access Issues for Women Living with HIV, Mental Illness, and Substance Abuse. AIDS Patient Care and STDs. 19(7). 449–459. 13 indexed citations
8.
GREGORY, Roland B., Robert A. Wilcox, Leise A. Berven, et al.. (1999). Evidence for the involvement of a small subregion of the endoplasmic reticulum in the inositol trisphosphate receptor-induced activation of Ca2+ inflow in rat hepatocytes. Biochemical Journal. 341(2). 401–401. 9 indexed citations
9.
Gibler, W. Brian, Robert A. Wilcox, Christoph Bode, et al.. (1998). Prospective Use of Glycoprotein IIb/IIIa Receptor Blockers in the Emergency Department Setting. Annals of Emergency Medicine. 32(6). 712–722. 4 indexed citations
10.
Wilcox, Robert A.. (1995). Textbook of Hypertension. BMJ. 310(6979). 609.1–609.1. 227 indexed citations
11.
Barbash, Gabriel I., Jonathan Reiner, H. D. White, et al.. (1995). Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: Mechanism of the “smoker's paradox” from the GUSTO-I trial, with angiographic insights. Journal of the American College of Cardiology. 26(5). 1222–1229. 198 indexed citations
12.
Hampton, John, Wolfgang Meyer‐Sabellek, Rolf Schröder, & Robert A. Wilcox. (1995). 715-6 lnternational Joint Efficacy Comparison of Thrombolytics (INJECT): Reteplase vs Streptokinase in Acute Myocardial Infarction. Journal of the American College of Cardiology. 25(2). 87A–87A. 2 indexed citations
13.
Wilcox, Robert A., et al.. (1982). Is exercise good for high blood pressure?. BMJ. 285(6344). 767–769. 95 indexed citations
14.
Wilcox, Robert A., et al.. (1981). Prognosis of patients with "chest pain ?cause".. BMJ. 282(6262). 431–433. 54 indexed citations
15.
Wilcox, Robert A., et al.. (1980). Sulphinpyrazone in acute myocardial infarction: studies on cardiac rhythm and renal function.. BMJ. 281(6239). 531–534. 16 indexed citations
16.
Wilcox, Robert A., J Roland, D C Banks, J R Hampton, & J.R.A. Mitchell. (1980). Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction.. BMJ. 280(6218). 885–888. 89 indexed citations
17.
Wilcox, Robert A.. (1980). Beta-blockers in immediate treatment of myocardial infarction. BMJ. 280(6224). 1187.3–1188. 1 indexed citations
18.
Roland, J, et al.. (1979). Effect of beta-blockers on arrhythmias during six weeks after suspected myocardial infarction. BMJ. 2(6189). 518–521. 29 indexed citations
19.
Wilcox, Robert A.. (1978). Beta-blockers in treatment of hypertension. BMJ. 2(6145). 1160.1–1160. 3 indexed citations
20.
Wilcox, Robert A.. (1978). Randomised study of six beta-blockers and a thiazide diuretic in essential hypertension. BMJ. 2(6134). 383–385. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philippe Lechat Breakdown of academic impact, for papers by Francesca Santilli Breakdown of academic impact, for papers by Lorenzo Loffredo Breakdown of academic impact, for papers by John Anthony Bauer Breakdown of academic impact, for papers by Shereif H. Rezkalla Breakdown of academic impact, for papers by Bobby V. Khan Breakdown of academic impact, for papers by Andreas J. Flammer Breakdown of academic impact, for papers by Susan B. Johnson Breakdown of academic impact, for papers by Emanuel Raschi Breakdown of academic impact, for papers by Marcello Ciaccio
Rankless by CCL
2026